SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-019395
Filing Date
2020-04-29
Accepted
2020-04-29 06:10:05
Documents
2
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A reta-defa14a_20200610.htm DEFA14A 26328
2 GRAPHIC gpjzrnfmzroq000001.jpg GRAPHIC 116640
  Complete submission text file 0001564590-20-019395.txt   188079
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37785 | Film No.: 20827163
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences